Stoll, Matthew, MD, PhD, MSCS


Associate Professor of Pediatrics
Division of Pediatric Rheumatology


Children's Park Place, Suite 210
1601 4th Avenue South
Birmingham, AL 35233-1711

Telephone: 205-638-9438



BS, Wesleyan University, Middletown, CT, 1994
MD, SUNY Upstate Medical University College of Medicine, Syracuse, NY, 2001
PhD, SUNY Upstate Medical University College of Medicine, Syracuse, NY, 2001
Intern (Pediatrics), Long Island Jewish Medical Center, New Hyde Park, NY, 2002
Resident (Pediatrics), Long Island Jewish Medical Center, New Hyde Park, NY, 2004
Fellow (Pediatric Rheumatology), Childrens Hospital Boston, Boston, MA, 2007
MSCS, UT Southwestern Medical Center, Dallas, TX, 2011


Awards and Honors

December 2014 Nominated, Birmingham Parent's List of Favorite Doctors
December 2012 Selected member, Society for Pediatric Research
July, 2004 Farley Fellowship Award (Childrens Hospital Boston; MA)
September, 2000 Alpha Omega Alpha (SUNY Upstate Medical University; Syracuse, NY)
April, 1994 Phi Beta Kappa (Wesleyan University; Middletown, CT)


Research Description

My major research interest is the link between mucosal immunity and spondyloarthritis. Specifically, I am looking at the adaptive (humoral and T cell) immune responses to enteric organisms and the nature of the fecal flora in patients with spondyloarthritis. I also am interested in the epidemiology, diagnosis, and treatment of temporomandibular joint (TMJ) arthritis in children with juvenile idiopathic arthritis (JIA).



Click here for a more complete list of publications. Below are a few selected papers

Tambralli A, Beukelman T, Cron RQ, and Stoll ML. 2015. Safety and efficacy of rituximab in childhood-onset lupus and other rheumatic diseases. Journal of Rheumatology 42:541-546. PMID: 25593242

Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, Cron RQ, Elson CO. 2014. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Research and Therapy 16:486. PMCID: PMC4272554

Stoll ML, Cron RQ. 2014. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatric Rheumatology 12:13. PMCID:PMC4003520

Stoll ML, Cron RQ. 2013. Treatment of juvenile idiopathic arthritis in the biologic age. Rheumatic Disease Clinics of North America 39: 751-766. PMID: 24182853

Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML. 2013. High doses of infliximab in the management of juvenile idiopathic arthritis. Journal of Rheumatology 40: 1749-1755. PMID: 23950184

Stoll ML, Morlandt A, Teerawattanapong S, Young D, Waite PD, Cron RQ. 2013. Safety and efficacy of intra-articular infliximab therapy for treatment resistant temporomandibular joint arthritis in children: a retrospective study. Rheumatology 52: 554-559. PMID: 23221325

Stoll, ML, Patel AS, Punaro M, Dempsey-Robertson M. 2012. MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritis. Pediatric Rheumatology 10:6. PMID: 22316421

Stoll ML, Good J, Sharpe T, Beukelman T, Young D, Waite PW, and Cron RQ. 2012. Intraarticular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis. Journal of Oral and Maxillofacial Surgery  70:1802-1807. PMID:22265164

Stoll ML, Sharpe T, Beukelman T, Good J, Young D., and Cron RQ. 2012. Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis. Journal of Rheumatology 39:1880 – 1887. PMID: 22589268

Stoll ML, Patel AS, Punaro M. 2011. Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J Rheumatol, 38: 2274 - 2275. PMID:21965700

Stoll ML, 2011. Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis. Clin Exp Rheumatol, 29: 322-330, PMID:21269576

Stoll ML, Nigrovic PA, Gotte AC, and Punaro M. 2011. Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis. Clin Exp Rheumatol,  29: 582-588. PMID: 21385553.

Stoll ML, Bhore R, Dempsey-Robertson M, Punaro M. 2010. Spondyloarthritis in a Pediatric population: Risk Factors for Sacroiliitis. J Rheumatol 37(11): 2402 - 2408. PMID: 20682668

Simard JF, Stoll ML, Shadick NA, Karlson EW, Solomon DH.  Validity of Self-report of Infections in a Longitudinal Cohort of Patients with Rheumatoid Arthritis Differs by Source of Report and Infection Severity J Clin Epi, 2010; 63:1358 - 1362. PMID: 20430581

Stoll ML and Gotte AC. Biological therapies for the treatment of juvenile idiopathic arthritis: lessons from adult and pediatric experiences. Biologics: Targets and Therapies 2008; 2(2): 229-252. PMID: 19707357

Stoll ML, Lio P, Sundel RP, Nigrovic PA. Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Care and Research 2008; 59(1): 51-58. PMID: 18163407 

Stoll ML, Zurakowski D, Nigrovic LE, Nichols DP, Sundel RP, and Nigrovic PA.  Patients with juvenile psoriatic arthritis comprise two distinct populations. Arthritis and Rheumatism 2006; 54 (11): 3564-3572. PMID: 17075862

Stoll ML, Nigrovic PA. Subpopulations within juvenile psoriatic arthritis: A review of the literature. Clinical and Developmental Immunology 2006; 13(2-4): 377-380. PMID: 17162381

Stoll ML and Rubin LG. Incidence of occult bacteremia among highly febrile young children presenting to a children's hospital emergency department or urgent care center in the era of the pneumococcal conjugate vaccine. Archives of Pediatric and Adolescent Medicine 2004; 158: 671-675. PMID: 15237067


SOM Epilogue Menu